Ping Jiang

Ping Jiang is a Principal Scientist at Moderna, with previous experience at Simnova Biotherapeutics, Creative Biolabs, Enzo Life Sciences, Inc., and Stony Brook University. Jiang has a strong background in virology, with a focus on the development of oncolytic viruses and vaccine candidates for diseases such as poliovirus, Dengue virus, and Zika virus. Additionally, Jiang has conducted research on enteroviruses and has contributed significantly to the understanding of molecular mechanisms in virology. Education includes a Ph.D. in Molecular Microbiology from Stony Brook University and a B.S. in Microbiology from Shandong University.